Clin2
NCT07172503Possibly a fitNot yet recruiting

PET imaging test for certain tumors

Colorectal CancerGastric Cancer (GC)Pancreatic Cancer

Part of Cancer, Digestive system, Hormones & metabolism clinical trials.

This trial is testing a new imaging method using a special tracer (GPA33) to find tumors in people with colorectal, gastric, or pancreatic cancer. It may help doctors see tumors more clearly during a PET scan.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
56 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have been diagnosed with or are suspected to have colorectal, gastric, or pancreatic cancer.
  • You can lie still for a PET/MR or PET/CT scan.
  • You are willing to use birth control if you could become pregnant.
  • You are able to sign a consent form and follow study procedures.
  • You do not have a known allergy to the GPA33 tracer.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07552467Recruiting
PET Imaging Scan for Detecting Cancer Using New Radioactive Tracer

This study tests a new type of imaging scan (PET/CT or PET/MR) that uses a radioactive tracer to help doctors better detect and diagnose various cancers. The scan targets a specific protein found in tumors, which may help identify cancer more accurately than standard imaging.

Wuhan, Hubei
NCT07219238Recruiting· Phase 2/Phase 3
PET scan for cancer spread in the abdomen

This trial tests a new PET/CT scan using a special tracer to detect cancer that has spread to the lining of the abdomen (peritoneal carcinomatosis) in people with colorectal, stomach, ovarian, or pancreatic cancer. It aims to see if this scan is better at finding the spread than standard imaging.

Grand Rapids, Michigan
NCT07702292Recruiting· Phase 2
68Ga-BED003 PET scan for certain cancers

This trial tests a new PET imaging agent that targets a protein called FAP, which appears in many solid tumors. The goal is to see if this scan can better find and measure cancer in the body.

Bergamo, Lombardy
NCT07432633Recruiting· Phase 1/Phase 2
Imaging scan to detect cancer-linked protein in several tumor types

This trial tests a new PET scan tracer that targets a protein found on certain cancer cells. It may help doctors better see and understand tumors in people with colorectal, gastric, pancreatic, lobular breast, or ovarian cancer.

Dallas, Texas
NCT07741006Enrolling by invitation· Early Phase 1
PET imaging study for adults with solid tumors

This study tests a new PET imaging agent called [68Ga]Ga-ELI411 to help see tumors more clearly. It is for adults with solid tumors who are already scheduled for a standard PET scan, and may help doctors better understand and manage their cancer.

Wuhan, Hubei
NCT06162988Not yet recruiting
PET scan with a new tracer for pancreatic, lung, or colorectal cancer

This study uses a special PET scan with a tracer called 68Ga-NOTA-H006 to look for cancer in people with pancreatic, lung, or colorectal cancer. It may help doctors see the cancer more clearly.

Shanghai

Hear when a new Colorectal cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.